Alprazolam and Myxoedema coma - a phase IV clinical study of FDA data

Summary:

Myxoedema coma is reported as a side effect among people who take Alprazolam (alprazolam), especially for people who are female, 60+ old, also take Lidoderm, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Myxoedema coma when taking Alprazolam. It is created by eHealthMe based on reports of 132,238 people who have side effects when taking Alprazolam from the FDA, and is updated regularly.

What is Alprazolam?

Alprazolam has active ingredients of alprazolam. It is often used in stress and anxiety. eHealthMe is studying from 134,864 Alprazolam users. Check the latest studies of Alprazolam.

What is Myxoedema coma?

Myxoedema coma (coma with long untreated hypothyroidism) is found to be associated with 31 drugs and 89 conditions by eHealthMe. Check the latest studies of Myxoedema coma.

On Jul, 29, 2026

132,238 people reported to have side effects when taking Alprazolam.
Among them, 11 people (0.01%) have Myxoedema coma.

Among these 11 people:

What is the gender of people who have Myxoedema coma when taking Alprazolam? *

female: 100 %
male: 0.0 %

What is the age of people who have Myxoedema coma when taking Alprazolam? *

What are other drugs people take besides Alprazolam? *

Lidoderm: 8 people, 72.73%
Oxycodone And Acetaminophen: 2 people, 18.18%
Mycostatin: 2 people, 18.18%
Medroxyprogesterone Acetate: 2 people, 18.18%
Lorazepam: 2 people, 18.18%
Indomethacin: 2 people, 18.18%
Chlorzoxazone: 2 people, 18.18%
Acetaminophen: 2 people, 18.18%
Nexterone: 1 person, 9.09%

What are other side effects people have besides Myxoedema coma? *

Sinus Bradycardia (an unusually slow heartbeat due to heart disease): 5 people, 45.45%
Anaemia (lack of blood): 4 people, 36.36%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 4 people, 36.36%
Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions): 4 people, 36.36%
Enlarged Heart: 3 people, 27.27%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 3 people, 27.27%
Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles): 3 people, 27.27%
Leukocytosis (increased white blood cells): 3 people, 27.27%
Tachypnea: 2 people, 18.18%
Haematochezia (passage of stools containing blood): 2 people, 18.18%

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 9 people, 81.82%

* Approximation only. Some reports may have incomplete information.

Do you take Alprazolam and have Myxoedema coma?

- Check whether Myxoedema coma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Alprazolam:

Alprazolam (134,864 reports)

Browse all side effects of Alprazolam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Myxoedema coma:

Myxoedema coma (31 drugs)

Browse all the conditions that are associated with Myxoedema coma:

Myxoedema coma (89 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on alprazolam (the active ingredients of Alprazolam) and Alprazolam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.